Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Jean‐François Emile(Université Paris-Saclay), Oussama Abla(University of Toronto), Sylvie Fraitag(Hôpital Necker-Enfants Malades), AnnaCarin Horne(Karolinska University Hospital), Julien Haroche(Sorbonne Université), Jean Donadieu(Université Paris-Saclay), Luis Requena‐Caballero(Hospital Universitario Fundación Jiménez Díaz), Michael B. Jordan(Cincinnati Children's Hospital Medical Center), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Carl E. Allen(Children's Cancer Center), Frédéric Charlotte(Sorbonne Université), Eli L. Diamond(Memorial Sloan Kettering Cancer Center), R. Maarten Egeler(University of Toronto), Alain Fischer(Délégation Paris 5), Juana Gil Herrera(Hospital General Universitario Gregorio Marañón), Jan‐Inge Henter(Karolinska University Hospital), Filip Jankú(The University of Texas MD Anderson Cancer Center), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Jennifer Picarsic(Children's Hospital of Pittsburgh), Carlos Rodríguez‐Galindo(Dana-Farber Cancer Institute), Barret J. Rollins(Brigham and Women's Hospital), Abdellatif Tazi(Hôpital Saint-Louis), Robert Vassallo(Mayo Clinic), Lawrence M. Weiss
Blood
March 10, 2016
Cited by 1,552Open Access
Full Text

Abstract

The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.


Related Papers

No related papers found

Powered by citation graph analysis